India’s COVAXIN Vaccine Gets Authorisation In 13 Nations; working On EUAs In 60 More + WHO
Photo courtesy: Republicworld
Bharat Biotech’s COVAXIN has made a massive leap into the global market as it announced that it has obtained the Emergency Use Authorization in 13 countries
While India continues to expedite COVID-19 vaccine production with an aim to provide on-demand jabs by August this year, Bharat Biotech’s COVAXIN has made a massive leap into the global market as it announced that it has obtained the Emergency Use Authorization (EUA) in 13 countries with more to follow. Read More…
- 26 May 2021
- WerIndia
Loading ...
